Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Sight Sciences Inc

SGHT
Current price
3.86 USD -0.12 USD (-3.02%)
Last closed 3.98 USD
ISIN US82657M1053
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 212 799 872 USD
Yield for 12 month +86.47 %
1Y
3Y
5Y
10Y
15Y
SGHT
21.11.2021 - 28.11.2021

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California. Address: 4040 Campbell Avenue, Menlo Park, CA, United States, 94025

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.46 USD

P/E ratio

Dividend Yield

Current Year

+81 056 000 USD

Last Year

+71 331 000 USD

Current Quarter

+20 157 000 USD

Last Quarter

+21 370 000 USD

Current Year

+69 175 000 USD

Last Year

+58 970 000 USD

Current Quarter

+16 907 000 USD

Last Quarter

+18 345 000 USD

Key Figures SGHT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -49 018 000 USD
Operating Margin TTM -55.71 %
PE Ratio
Return On Assets TTM -19.41 %
PEG Ratio
Return On Equity TTM -45.36 %
Wall Street Target Price 5.46 USD
Revenue TTM 79 543 000 USD
Book Value 1.88 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 0.7 %
Dividend Yield
Gross Profit TTM 58 970 000 USD
Earnings per share -1.06 USD
Diluted Eps TTM -1.06 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -63.3 %

Dividend Analytics SGHT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History SGHT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation SGHT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.6329
Price Sales TTM 2.6753
Enterprise Value EBITDA -4.2469
Price Book MRQ 2.0937

Financials SGHT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SGHT

For 52 weeks

1.8 USD 8.45 USD
50 Day MA 5.93 USD
Shares Short Prior Month 1 079 756
200 Day MA 5.8 USD
Short Ratio 7.77
Shares Short 1 115 220
Short Percent 3.03 %